ZN-c3
ZN-c3-016
Phase 1 small_molecule terminated
Quick answer
ZN-c3 for Metastatic Colorectal Cancer is a Phase 1 program (small_molecule) at Zentalis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zentalis Pharmaceuticals
- Indication
- Metastatic Colorectal Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated